GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Indivior PLC (FRA:2IVB) » Definitions » Cyclically Adjusted Price-to-FCF

Indivior (FRA:2IVB) Cyclically Adjusted Price-to-FCF : 14.11 (As of May. 18, 2024)


View and export this data going back to 2015. Start your Free Trial

What is Indivior Cyclically Adjusted Price-to-FCF?

As of today (2024-05-18), Indivior's current share price is €15.80. Indivior's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2024 was €1.12. Indivior's Cyclically Adjusted Price-to-FCF for today is 14.11.

The historical rank and industry rank for Indivior's Cyclically Adjusted Price-to-FCF or its related term are showing as below:

FRA:2IVB' s Cyclically Adjusted Price-to-FCF Range Over the Past 10 Years
Min: 9.4   Med: 13.82   Max: 18.23
Current: 14.23

During the past years, Indivior's highest Cyclically Adjusted Price-to-FCF was 18.23. The lowest was 9.40. And the median was 13.82.

FRA:2IVB's Cyclically Adjusted Price-to-FCF is ranked better than
81.71% of 328 companies
in the Drug Manufacturers industry
Industry Median: 33.52 vs FRA:2IVB: 14.23

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

Indivior's adjusted free cash flow per share data for the three months ended in Mar. 2024 was €-0.378. Add all the adjusted free cash flow per share for the past 10 years together and divide 10 will get our Cyclically Adjusted FCF per Share, which is €1.12 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Indivior Cyclically Adjusted Price-to-FCF Historical Data

The historical data trend for Indivior's Cyclically Adjusted Price-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Indivior Cyclically Adjusted Price-to-FCF Chart

Indivior Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted Price-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - 11.79

Indivior Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted Price-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 10.95 14.79 14.73 11.79 17.84

Competitive Comparison of Indivior's Cyclically Adjusted Price-to-FCF

For the Drug Manufacturers - Specialty & Generic subindustry, Indivior's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Indivior's Cyclically Adjusted Price-to-FCF Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Indivior's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Indivior's Cyclically Adjusted Price-to-FCF falls into.



Indivior Cyclically Adjusted Price-to-FCF Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted Price-to-FCF takes the Free Cash Flow per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/FCF calculation. Because it considers this 10-year average, it's often referred to as the CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF.

Indivior's Cyclically Adjusted Price-to-FCF for today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/ Cyclically Adjusted FCF per Share
=15.80/1.12
=14.11

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Indivior's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, Indivior's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2024 was:

Adj_FreeCashFlowPerShare=Free Cash Flow per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=-0.378/131.7762*131.7762
=-0.378

Current CPI (Mar. 2024) = 131.7762.

Indivior Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201406 1.098 100.560 1.439
201409 0.651 100.428 0.854
201412 0.147 99.070 0.196
201503 1.053 99.621 1.393
201506 0.334 100.684 0.437
201509 0.328 100.392 0.431
201512 0.288 99.792 0.380
201603 0.571 100.470 0.749
201606 0.460 101.688 0.596
201609 0.522 101.861 0.675
201612 0.733 101.863 0.948
201703 0.325 102.862 0.416
201706 0.695 103.349 0.886
201709 0.146 104.136 0.185
201712 0.322 104.011 0.408
201803 0.097 105.290 0.121
201806 0.325 106.317 0.403
201809 0.588 106.507 0.728
201812 0.489 105.998 0.608
201903 0.778 107.251 0.956
201906 -0.369 108.070 -0.450
201909 0.228 108.329 0.277
201912 0.215 108.420 0.261
202003 -0.850 108.902 -1.029
202006 -0.011 108.767 -0.013
202009 0.143 109.815 0.172
202012 -0.383 109.897 -0.459
202103 0.478 111.754 0.564
202106 0.378 114.631 0.435
202109 0.737 115.734 0.839
202112 1.052 117.630 1.179
202203 -0.466 121.301 -0.506
202206 0.173 125.017 0.182
202209 0.427 125.227 0.449
202212 -0.125 125.222 -0.132
202303 -0.278 127.348 -0.288
202306 -0.129 128.729 -0.132
202309 -0.046 129.860 -0.047
202312 -1.956 129.419 -1.992
202403 -0.378 131.776 -0.378

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Indivior  (FRA:2IVB) Cyclically Adjusted Price-to-FCF Explanation

Compared with the regular Price-to-Free-Cash-Flow, which works poorly for cyclical businesses, the Cyclically Adjusted Price-to-FCF smoothed out the fluctuations of free cash flow during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted Price-to-FCF should give similar results to regular Price-to-Free-Cash-Flow.


Indivior Cyclically Adjusted Price-to-FCF Related Terms

Thank you for viewing the detailed overview of Indivior's Cyclically Adjusted Price-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Indivior (FRA:2IVB) Business Description

Industry
Traded in Other Exchanges
Address
234 Bath Road, Slough, Berkshire, GBR, SL1 4EE
Indivior PLC is a specialty and generic drug manufacturing company. The company is focused on the development, manufacture, and sale of prescription drugs based on buprenorphine for treatment of opioid dependence. The vast majority of Indivior's revenue is generated in the United States, followed by the rest of the world. The company considers merger and acquisition investment to be a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.

Indivior (FRA:2IVB) Headlines

No Headlines